OrbiMed Royalties V Private Investors, LLC
OrbiMed Royalties V Private Investors, LLC is a private equity fund based in New York, New York. According to its most recent Form D, filed Aug 8, 2025, it has sold $48,975,000 of interests to 70 investors since its first sale in Jul 2025. The minimum investment it accepts from an outside investor is $250,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Robert Meschi; Grant Cellier; J.P. Morgan Private Investments Inc.
- Total raised
- $48,975,000Cumulative sales reported on Form D
- Investors
- 70
- First sale
- Jul 30, 2025
- Minimum investment
- $250,000
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Robert Meschi; Grant Cellier; J.P. Morgan Private Investments Inc
- Latest Form D
- Aug 8, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about OrbiMed Royalties V Private Investors, LLC
What is the minimum investment for OrbiMed Royalties V Private Investors, LLC?
According to its latest Form D, filed Aug 8, 2025, the minimum investment OrbiMed Royalties V Private Investors, LLC accepts from an outside investor is $250,000.
Who can invest in OrbiMed Royalties V Private Investors, LLC?
OrbiMed Royalties V Private Investors, LLC is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has OrbiMed Royalties V Private Investors, LLC raised?
OrbiMed Royalties V Private Investors, LLC reports $48,975,000 sold from 70 investors on its Form D filed Aug 8, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is OrbiMed Royalties V Private Investors, LLC based?
OrbiMed Royalties V Private Investors, LLC is based in New York, New York and is managed by J.P. Morgan Private Investments Inc..
When did OrbiMed Royalties V Private Investors, LLC launch?
OrbiMed Royalties V Private Investors, LLC reports its first sale in Jul 2025, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every private equity fund
Raised more than 70% of the 3,770 private equity funds based in New York, and more than 63% of all 9,142 that report sales.
Other funds with the same team
- CPI (Carlyle Property) Private Investors, LLC$569M
- Clarion Private Investors, LLC$521M
- SOF XIII Private Investors, LLC$519M
- Strategic Partners X Private Investors, LLC$515M
- KKR North America XIV Private Investors Offshore SICAV-RAIF S.C.Sp.$470M
- SVSS VI Private Investors, LLC$432M
- TVC Fund IX Private Investors Offshore, L.P.$389M
- KKR North America XIV Private Investors, LLC$343M